Qiaofei Liu

3.4k total citations
97 papers, 2.4k citations indexed

About

Qiaofei Liu is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Qiaofei Liu has authored 97 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 34 papers in Immunology and 31 papers in Surgery. Recurrent topics in Qiaofei Liu's work include Pancreatic and Hepatic Oncology Research (42 papers), Immune cells in cancer (19 papers) and Pancreatitis Pathology and Treatment (14 papers). Qiaofei Liu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (42 papers), Immune cells in cancer (19 papers) and Pancreatitis Pathology and Treatment (14 papers). Qiaofei Liu collaborates with scholars based in China, Germany and United States. Qiaofei Liu's co-authors include Quan Liao, Yupei Zhao, Sen Yang, Yalu Zhang, Ronghua Zhang, Quan Liao, Xiang Zhang, Ming Cui, Tong Li and Mengyi Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Qiaofei Liu

88 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaofei Liu China 30 1.1k 940 754 661 291 97 2.4k
Brian M. Necela United States 24 691 0.6× 1.1k 1.1× 366 0.5× 592 0.9× 147 0.5× 52 2.2k
Hao Zhao United States 18 1.6k 1.5× 1.0k 1.1× 1.3k 1.8× 391 0.6× 489 1.7× 33 3.1k
Huafeng Wei China 27 819 0.8× 672 0.7× 974 1.3× 220 0.3× 122 0.4× 57 2.1k
Abir Mukherjee United States 32 513 0.5× 2.0k 2.1× 407 0.5× 849 1.3× 183 0.6× 82 3.6k
Matthew R. Ramsey United States 18 735 0.7× 1.9k 2.1× 393 0.5× 403 0.6× 200 0.7× 25 3.4k
Alberto Benguría Spain 20 542 0.5× 1.8k 1.9× 381 0.5× 352 0.5× 154 0.5× 58 3.1k
Soyoung Lee Germany 17 887 0.8× 2.0k 2.2× 578 0.8× 436 0.7× 165 0.6× 33 3.2k
André Lechel Germany 25 595 0.6× 1.3k 1.4× 309 0.4× 378 0.6× 181 0.6× 54 2.5k
Hsei–Wei Wang Taiwan 25 977 0.9× 1.2k 1.3× 315 0.4× 721 1.1× 207 0.7× 43 2.6k
Yingxi Xu China 24 879 0.8× 943 1.0× 570 0.8× 294 0.4× 106 0.4× 77 2.0k

Countries citing papers authored by Qiaofei Liu

Since Specialization
Citations

This map shows the geographic impact of Qiaofei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaofei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaofei Liu more than expected).

Fields of papers citing papers by Qiaofei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaofei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaofei Liu. The network helps show where Qiaofei Liu may publish in the future.

Co-authorship network of co-authors of Qiaofei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaofei Liu. A scholar is included among the top collaborators of Qiaofei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaofei Liu. Qiaofei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Junliang, Liangrui Zhou, Taiping Zhang, et al.. (2025). Molecular profiling reveals the malignant potential in solid pseudopapillary neoplasms of the pancreas. Cancer Letters. 625. 217788–217788. 1 indexed citations
2.
Hua, Yuze, Sen Yang, Vincent Liu, et al.. (2025). Epigenetic modification and tumor immunity: Unraveling the interplay with the tumor microenvironment and its therapeutic vulnerability and implications. Cancer Letters. 616. 217587–217587. 2 indexed citations
3.
4.
5.
Yuan, Shangqin, Jiayi Li, Xudong Liu, et al.. (2024). Chimeric antigen receptor macrophages targeting c-MET(CAR-M-c-MET) inhibit pancreatic cancer progression and improve cytotoxic chemotherapeutic efficacy. Molecular Cancer. 23(1). 270–270. 18 indexed citations
6.
Zhang, Ronghua, Junya Peng, Yalu Zhang, et al.. (2024). Pancreatic cancer cell-derived migrasomes promote cancer progression by fostering an immunosuppressive tumor microenvironment. Cancer Letters. 605. 217289–217289. 26 indexed citations
7.
Liu, Wenjing, Bo Ren, Lixin Chen, et al.. (2024). Comparisons of laparoscopic and robotic pancreaticoduodenectomy using barbed and conventional sutures for pancreaticojejunostomy: a propensity score matching study. Surgical Endoscopy. 38(10). 5858–5868. 4 indexed citations
8.
Liu, Qiaofei, Jiayi Li, Sen Yang, et al.. (2023). Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T. Molecular Cancer. 22(1). 28–28. 89 indexed citations
9.
Yang, Sen, Yalu Zhang, Yuze Hua, et al.. (2023). Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases. Frontiers in Oncology. 12. 1007317–1007317. 3 indexed citations
10.
Ding, Jie, Jiangdong Qiu, Zhixin Hao, et al.. (2023). Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. European Journal of Nuclear Medicine and Molecular Imaging. 50(13). 4036–4050. 16 indexed citations
11.
Ding, Jie, Jiangdong Qiu, Zhixin Hao, et al.. (2023). Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics. European Journal of Nuclear Medicine and Molecular Imaging. 50(6). 1780–1791. 26 indexed citations
12.
Zhang, Yalu, Qiaofei Liu, Ming Cui, et al.. (2022). Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma. Frontiers in Immunology. 12. 774435–774435. 13 indexed citations
13.
Zhang, Hui, Xiaoqian Liu, Qiaofei Liu, et al.. (2022). Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth. Cancer Letters. 555. 216040–216040. 29 indexed citations
14.
Zhang, Yalu, Qiaofei Liu, Sen Yang, & Quan Liao. (2021). CD58 Immunobiology at a Glance. Frontiers in Immunology. 12. 705260–705260. 39 indexed citations
15.
Liu, Qiaofei, Huanwen Wu, Yuan Li, et al.. (2020). Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment. Cancer Immunology Immunotherapy. 69(8). 1477–1492. 45 indexed citations
16.
17.
Zhang, Ronghua, Qiaofei Liu, Tong Li, Quan Liao, & Yupei Zhao. (2019). Role of the complement system in the tumor microenvironment. Cancer Cell International. 19(1). 300–300. 89 indexed citations
18.
Zhang, Ronghua, Qiaofei Liu, Quan Liao, & Yupei Zhao. (2018). CD59: A Promising Target for Tumor Immunotherapy. Future Oncology. 14(8). 781–791. 53 indexed citations
19.
Liu, Wei, Qiaofei Liu, Wen-Qin Wang, et al.. (2018). Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant. Journal of Cancer. 9(10). 1804–1812. 28 indexed citations
20.
Zhang, Zhuohan, Qiaofei Liu, Yongzhe Che, et al.. (2009). Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3. Cancer Research. 70(1). 89–98. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian M. Necela Breakdown of academic impact, for papers by Hao Zhao Breakdown of academic impact, for papers by Huafeng Wei Breakdown of academic impact, for papers by Abir Mukherjee Breakdown of academic impact, for papers by Matthew R. Ramsey Breakdown of academic impact, for papers by Alberto Benguría Breakdown of academic impact, for papers by Soyoung Lee Breakdown of academic impact, for papers by André Lechel Breakdown of academic impact, for papers by Hsei–Wei Wang Breakdown of academic impact, for papers by Yingxi Xu
Rankless by CCL
2026